Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01120678 · ClinicalTrials.gov registry record
Improved Detection of Neonatal Sepsis Using a Targeted Biomarker Assay
A clinical trial, sponsored by University of Virginia.
- Completed
- Registry status
- 250
- Enrollment target
NCT01120678 is a clinical trial that has completed, run by University of Virginia. The registered enrollment target is 250 participants.
The verdict
NCT01120678 has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- 250 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether analysis of specific serum biomarkers will improve the diagnosis of late onset neonatal sepsis and to determine the correlation between plasma levels of specific cytokines and bacteremia in NICU patients \>3 days of age.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2009-02 |
| Est. Completion | 2010-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01120678
The ClinicalTrials.gov registry entry for NCT01120678 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01120678 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01120678 about?
NCT01120678 is a clinical study titled "Improved Detection of Neonatal Sepsis Using a Targeted Biomarker Assay". The purpose of this study is to determine whether analysis of specific serum biomarkers will improve the diagnosis of late onset neonatal sepsis and to determine the correlation between plasma levels of specific cytokines and bacteremia in NICU patients \>3 days of age.
What is the current status of trial NCT01120678?
This trial is currently completed. The enrollment target is 250 participants. The study started on 2009-02. Estimated completion is 2010-07.
Who is sponsoring clinical trial NCT01120678?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.